NovaBridge Biosciences (NBP) Stock Statistics & Valuation Metrics

NovaBridge Biosciences has a market cap or net worth of $271.15M. The enterprise value is $1.64B.

NovaBridge Biosciences has 115,381,690 shares outstanding. The number of shares has decreased by -2.65% in one year.

NovaBridge Biosciences’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -274.53%.

The current PE Ratio of NovaBridge Biosciences is ―. NovaBridge Biosciences’s PEG ratio is 0.65.

In the last 12 months, NovaBridge Biosciences had revenue of 0.00 and earned -46.27M in profits. Earnings per share was -0.48.

In the last 12 months, operating cash flow was -1.45M and capital expenditures 41.00, giving a free cash flow of -1.45M billion.

NovaBridge Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

NovaBridge Biosciences upcoming earnings date is May 14, 2026, Before Open (Confirmed).

NovaBridge Biosciences as a current ratio of 8.09, with Debt / Equity ratio of 1.33%

In the past 12 months, NovaBridge Biosciences has paid 0.00 in taxes.

NovaBridge Biosciences EV to EBITDA ratio is -26.31, with an EV/FCF ratio of -119.28.

NovaBridge Biosciences has $210.84M in cash and marketable securities with $3.07M in debt, giving a net cash position of $207.78M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for NovaBridge Biosciences is $9.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy